AstraZeneca Pharma India Limited has secured shareholder approval for the shifting of its registered office from the State of Karnataka to the State of Maharashtra, along with a consequential amendment to the second clause of its Memorandum of Association (MOA). The Special Resolution was passed through a postal ballot process, with the voting results declared on May 12, 2026, by Company Secretary and Compliance Officer Tanya Sanish. Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company intimated the stock exchanges of this development. The approval is subject to receipt of requisite regulatory approvals, including those under the Companies Act, 2013 and rules framed thereunder.

Postal Ballot Process and Voting Window

The postal ballot was initiated pursuant to a notice dated March 11, 2026, and members were invited to cast their votes electronically. The e-voting window was open from Sunday, April 12, 2026 (9:00 am IST) to Monday, May 11, 2026 (5:00 pm IST), through the National Securities Depository Limited (NSDL) e-voting platform at www.evoting.nsdl.com . The record date for determining eligible shareholders was April 3, 2026, on which date the total number of shareholders stood at 29,618. In accordance with applicable MCA Circulars, the postal ballot notice was sent in electronic form only, and all voting was conducted exclusively through the remote e-voting system. A total of 274 members (folio-wise) cast their votes through remote e-voting.

Scrutinizer Appointment and Report

Mr. Vijayakrishna K.T., Company Secretary in Whole-Time Practice (FCS No. 1788, CP No. 980), was appointed as Scrutinizer by the Company's Board at its meeting held on March 11, 2026. His report, issued on May 12, 2026, confirmed that the voting process was conducted in a fair and transparent manner. The scrutinizer's findings were based on data derived from the NSDL e-voting platform and covered votes cast by shareholders holding equity shares in both physical and electronic mode.

Voting Results

The Special Resolution was passed with requisite majority. The following table summarises the overall voting outcome as reported by the Scrutinizer:

The detailed category-wise breakdown of votes polled is presented below:

There were no invalid votes recorded across any shareholder category — Promoter and Promoter Group, Public Institutions, or Public Non-Institutions.

Key Details of the Resolution

• Resolution Type: Special Resolution
• Subject: Shifting of the registered office from the State of Karnataka to the State of Maharashtra and consequential amendment to the Memorandum of Association
• Promoter/Promoter Group Interest in Resolution: No
• Resolution Status: Passed

The voting results and the Scrutinizer's Report have been made available on the company's website at www.astrazeneca.com/india and on the NSDL e-voting website at www.evoting.nsdl.com , in compliance with applicable regulatory requirements.

AstraZeneca Pharma India Limited has announced a postal ballot process to seek shareholder approval for relocating its registered office from Karnataka to Maharashtra. The pharmaceutical company issued the formal notice on March 11, 2026, outlining the special business proposal and voting procedures.

Postal Ballot Timeline and Process

The company has established a comprehensive timeline for the postal ballot process, with specific dates for shareholder participation:

Shareholders whose names appear in the Register of Members or Record of Depositories as on the cut-off date of Friday, April 3, 2026, will be eligible to participate in the voting process. The company has engaged National Securities Depository Limited (NSDL) to facilitate the remote e-voting process in a secure manner.

Proposed Registered Office Relocation

The special resolution seeks approval for shifting the company's registered office from its current location in Karnataka to the State of Maharashtra. The current registered office is situated at Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Outer Ring Road, Bengaluru - 560045.

The proposed relocation aims to enhance administrative and operational efficiency as the company builds a stronger footprint in Mumbai, Maharashtra. This strategic move aligns with the company's commitment to transforming health outcomes for patients across India.

Regulatory Requirements and Approvals

The proposed office relocation requires multiple levels of approval in accordance with regulatory provisions:

• Shareholder Approval: Special resolution through postal ballot voting
• Central Government Approval: Through the appropriate Regional Director
• Memorandum Amendment: Alteration of the 2nd Clause of the Memorandum of Association

The resolution is being conducted pursuant to Sections 12, 13, 108, and 110 of the Companies Act, 2013, along with applicable rules and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

E-voting Process and Accessibility

The postal ballot notice is being distributed exclusively through electronic mode to shareholders whose email addresses are registered with the company or depositories. The company has provided detailed instructions for various categories of shareholders, including those holding securities in demat mode with NSDL or CDSL, and those holding physical shares.

Shareholders can access the voting platform through multiple methods, including the NSDL e-voting website at www.evoting.nsdl.com and through their respective depository participant platforms. The company has also made provisions for shareholders whose email addresses are not registered to participate in the voting process.

Documentation and Compliance

The postal ballot notice includes comprehensive explanatory statements pursuant to Section 102 of the Companies Act, 2013, detailing the material facts and reasons for the proposed resolution. The notice will be published in English and regional newspapers as required by regulatory provisions.

Mr. Vijayakrishna K.T, a Practising Company Secretary from Bengaluru, has been appointed as the Scrutinizer to conduct the postal ballot process in a fair and transparent manner. The scrutinizer will submit the results report to the Chairperson on or before Wednesday, May 13, 2026, following the completion of vote counting.

The resolution, if approved with the requisite majority, will be deemed to have been passed on the last date of the voting period, May 11, 2026, in accordance with Secretarial Standards on General Meetings issued by the Institute of Company Secretaries of India.